Dianthus Therapeutics, Inc. /DE/ Quarterly Common Stock, Shares, Outstanding from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2017 to Q3 2024.
  • Dianthus Therapeutics, Inc. /DE/ Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 29.4M shares, a 98.2% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 29.4M +14.5M +98.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 29.4M -31.3M -51.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 29.3M -31.3M -51.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 14.8M +13.9M +1593% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 14.8M -45.7M -75.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 60.7M +1.85M +3.15% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 60.6M +1.85M +3.15% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 875K 0 0% Dec 31, 2022 10-K 2024-03-21
Q3 2022 60.6M +1.78M +3.03% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 58.8M +290K +0.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 58.8M +10.2M +21% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 875K -47.7M -98.2% Dec 31, 2021 8-K 2023-12-21
Q3 2021 58.8M +10.5M +21.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 58.5M +10.3M +21.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 48.6M +9.15M +23.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 48.5M +9.27M +23.6% Dec 31, 2020 10-K 2022-03-08
Q3 2020 48.3M +9.35M +24% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 48.2M +9.53M +24.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 39.5M +5.87M +17.5% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 39.3M +5.96M +17.9% Dec 31, 2019 10-K 2021-03-03
Q3 2019 38.9M +5.84M +17.6% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 38.7M +5.82M +17.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 33.6M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 33.3M +31M +1316% Dec 31, 2018 10-K 2020-03-03
Q3 2018 33.1M Sep 30, 2018 10-Q 2018-11-08
Q2 2018 32.9M Jun 30, 2018 10-Q 2018-08-09
Q4 2017 2.35M Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.